Clinical Trials List
2021-08-01 - 2029-12-31
Phase III
Recruiting6
ICD-10C67.0
Malignant neoplasm of trigone of bladder
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9188.0
Malignant neoplasm of trigone of urinary bladder
-
Trial Applicant
COVANCE TAIWAN SERVICES LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ching-Chan Lin 無
- Chi-Ping Huang 無
- Po-Jen Hsiao 無
- Wei-Ching Lin 無
- Su-Peng Yeh 無
- Hsi-Chin Wu 無
- Yi-Huei Chang 無
- 謝德鈞 無
- Chi-Rei Yang 無
- 陳冠亨 無
- Yu-De Wang 無
- Che-Hung Lin 無
- Po-Fan Hsieh 無
- Chin-Chung Yeh 無
- Han Chang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
26 participants
-
Global
943 participants
